Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra BioMed enter global...
Orchestra BioMed and Terumo have formed a global strategic partnership for the development and commercialisation of Virtue sirolimus-eluting balloon (SEB) in the percutaneous coronary...
Cardiologists can help to avert nuclear doomsday
Cardiologists can help to reduce the threat of nuclear war and move “the hands of the Doomsday Clock back from the midnight hour”, according...
PCR statement on TAVI signals “paradigm shift” in treatment of severe symptomatic AS
Evolving indications for the use of transcatheter aortic valve implantation (TAVI) have led to a series of “paradigm shifts” in the treatment of severe...
Early treatment with Helix system improves ejection fraction and symptoms
The Helix biotherapeutic delivery system (Biocardia), which delivers cell therapy to patients within four weeks of a heart attack, led to improved ejection fraction...
(Visited 18,633 times, 16 visits today)
